Lista de obras -

4-methoxycarbonyl curcumin: a unique inhibitor of both inflammatory mediators and periodontal inflammation

artículo científico publicado en 2013

A Chemically Modified Curcumin (CMC 2.24) Inhibits Nuclear Factor κB Activation and Inflammatory Bone Loss in Murine Models of LPS-Induced Experimental Periodontitis and Diabetes-Associated Natural Periodontitis.

artículo científico publicado en 2017

A Novel Chemically Modified Curcumin "Normalizes" Wound-Healing in Rats with Experimentally Induced Type I Diabetes: Initial Studies

artículo científico publicado en 2016

A Tetracycline Analog Improves Acute Respiratory Distress Syndrome Survival in an Ovine Model ⬇️

artículo científico publicado el 1 de agosto de 2010

A chemically modified tetracycline (CMT-3) is a new antifungal agent

artículo científico publicado en 2002

A novel chemically modified curcumin reduces severity of experimental periodontal disease in rats: initial observations

artículo científico publicado en 2014

Alveolar instability causes early ventilator-induced lung injury independent of neutrophils

artículo científico publicado en 2004

Association of gingival crevicular fluid biomarkers during periodontal maintenance with subsequent progressive periodontitis.

artículo científico publicado en 2010

Characteristics of collagenase-2 from gingival crevicular fluid and peri-implant sulcular fluid in periodontitis and peri-implantitis patients: pilot study

artículo científico publicado en 2008

Chemically Modified Tetracycline 3 Prevents Acute Respiratory Distress Syndrome in a Porcine Model of Sepsis + Ischemia/Reperfusion–Induced Lung Injury ⬇️

artículo científico publicado el 1 de abril de 2012

Chemically modified tetracycline improves contractility in porcine coronary ischemia/reperfusion injury

artículo científico publicado en 2006

Chemically modified tetracycline prevents the development of septic shock and acute respiratory distress syndrome in a clinically applicable porcine model

artículo científico publicado en 2005

Chemically modified tetracycline-3 (CMT-3): A novel inhibitor of the serine proteinase, elastase ⬇️

artículo científico publicado el 31 de mayo de 2011

Chemically-Modified Curcumin 2.24: A Novel Systemic Therapy for Natural Periodontitis in Dogs

artículo científico publicado en 2020

Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial

artículo científico publicado en 2004

Design, Synthesis and Biological Activity of New Polyenolic Inhibitors of Matrix Metalloproteinases: A Focus on Chemically-Modified Curcumins ⬇️

artículo científico publicado el 1 de enero de 2012

Differential effects of natural Curcumin and chemically modified curcumin on inflammation and bone resorption in model of experimental periodontitis.

artículo científico publicado en 2018

Doxycycline [corrected] inhibits mononuclear cell-mediated connective tissue breakdown

scientific article published on 10 November 2009

Effect of positive end-expiratory pressure and tidal volume on lung injury induced by alveolar instability

artículo científico publicado en 2007

Efficacy of sub-antimicrobial dose doxycycline in post-menopausal women: clinical outcomes

artículo científico publicado en 2007

Enhanced efficacy of chemically modified curcumin in experimental periodontitis: systemic implications

Evidence of systemic cytokine release in patients undergoing cardiopulmonary bypass

artículo científico publicado en 2005

Impact of chemically-modified tetracycline 3 on intertwined physiological, biochemical, and inflammatory networks in porcine sepsis/ARDS.

artículo científico publicado en 2015

Inflammatory mediator release following bone grafting in humans: a pilot study

scientific article published on 01 September 2007

Inhibition of breast cancer cell extracellular matrix degradative activity by chemically modified tetracyclines

artículo científico publicado en 2005

Local biochemical markers of bone turnover: relationship to subsequent density of healing alveolar bone defects

artículo científico publicado en 2004

Loss of alveolar bone density in postmenopausal, osteopenic women is associated with circulating levels of gelatinases

artículo científico publicado en 2019

Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation.

artículo científico publicado en 2006

Metalloproteinase inhibition reduces lung injury and improves survival after cecal ligation and puncture in rats

artículo científico publicado en 2003

Non-antibacterial tetracyclines modulate mediators of periodontitis and atherosclerotic cardiovascular disease: A mechanistic link between local and systemic inflammation ⬇️

artículo científico publicado el 13 de julio de 2011

Osteoimmunology of Oral and Maxillofacial Diseases: Translational Applications Based on Biological Mechanisms

artículo científico publicado en 2019

Periodontal therapeutics: Current host-modulation agents and future directions

scientific article published on 01 February 2020

Potato dextrose agar antifungal susceptibility testing for yeasts and molds: evaluation of phosphate effect on antifungal activity of CMT-3

artículo científico publicado en 2002

Subantimicrobial dose doxycycline effects on alveolar bone loss in post-menopausal women

artículo científico publicado en 2007

Subantimicrobial dose doxycycline effects on osteopenic bone loss: microbiologic results

artículo científico publicado en 2007

Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinase inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal anti-inflammatory drug

artículo científico publicado en 2004

Subantimicrobial-dose doxycycline modulates gingival crevicular fluid biomarkers of periodontitis in postmenopausal osteopenic women

artículo científico publicado en 2008

Subantimicrobial-dose doxycycline treatment increases serum cholesterol efflux capacity from macrophages

artículo científico publicado en 2013

The effect of subantimicrobial-dose-doxycycline periodontal therapy on serum biomarkers of systemic inflammation: a randomized, double-masked, placebo-controlled clinical trial

artículo científico publicado en 2011

Lista de obras de

4-methoxycarbonyl curcumin: a unique inhibitor of both inflammatory mediators and periodontal inflammation

A Chemically Modified Curcumin (CMC 2.24) Inhibits Nuclear Factor κB Activation and Inflammatory Bone Loss in Murine Models of LPS-Induced Experimental Periodontitis and Diabetes-Associated Natural Periodontitis.

A Novel Chemically Modified Curcumin "Normalizes" Wound-Healing in Rats with Experimentally Induced Type I Diabetes: Initial Studies

A Tetracycline Analog Improves Acute Respiratory Distress Syndrome Survival in an Ovine Model ⬇️

A chemically modified tetracycline (CMT-3) is a new antifungal agent

A novel chemically modified curcumin reduces severity of experimental periodontal disease in rats: initial observations

Alveolar instability causes early ventilator-induced lung injury independent of neutrophils

Association of gingival crevicular fluid biomarkers during periodontal maintenance with subsequent progressive periodontitis.

Characteristics of collagenase-2 from gingival crevicular fluid and peri-implant sulcular fluid in periodontitis and peri-implantitis patients: pilot study

Chemically Modified Tetracycline 3 Prevents Acute Respiratory Distress Syndrome in a Porcine Model of Sepsis + Ischemia/Reperfusion–Induced Lung Injury ⬇️

Chemically modified tetracycline improves contractility in porcine coronary ischemia/reperfusion injury

Chemically modified tetracycline prevents the development of septic shock and acute respiratory distress syndrome in a clinically applicable porcine model

Chemically modified tetracycline-3 (CMT-3): A novel inhibitor of the serine proteinase, elastase ⬇️

Chemically-Modified Curcumin 2.24: A Novel Systemic Therapy for Natural Periodontitis in Dogs

Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial

Design, Synthesis and Biological Activity of New Polyenolic Inhibitors of Matrix Metalloproteinases: A Focus on Chemically-Modified Curcumins ⬇️

Differential effects of natural Curcumin and chemically modified curcumin on inflammation and bone resorption in model of experimental periodontitis.

Doxycycline [corrected] inhibits mononuclear cell-mediated connective tissue breakdown

Effect of positive end-expiratory pressure and tidal volume on lung injury induced by alveolar instability

Efficacy of sub-antimicrobial dose doxycycline in post-menopausal women: clinical outcomes

Enhanced efficacy of chemically modified curcumin in experimental periodontitis: systemic implications

Evidence of systemic cytokine release in patients undergoing cardiopulmonary bypass

Impact of chemically-modified tetracycline 3 on intertwined physiological, biochemical, and inflammatory networks in porcine sepsis/ARDS.

Inflammatory mediator release following bone grafting in humans: a pilot study

Inhibition of breast cancer cell extracellular matrix degradative activity by chemically modified tetracyclines

Local biochemical markers of bone turnover: relationship to subsequent density of healing alveolar bone defects

Loss of alveolar bone density in postmenopausal, osteopenic women is associated with circulating levels of gelatinases

Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation.

Metalloproteinase inhibition reduces lung injury and improves survival after cecal ligation and puncture in rats

Non-antibacterial tetracyclines modulate mediators of periodontitis and atherosclerotic cardiovascular disease: A mechanistic link between local and systemic inflammation ⬇️

Osteoimmunology of Oral and Maxillofacial Diseases: Translational Applications Based on Biological Mechanisms

Periodontal therapeutics: Current host-modulation agents and future directions

Potato dextrose agar antifungal susceptibility testing for yeasts and molds: evaluation of phosphate effect on antifungal activity of CMT-3

Subantimicrobial dose doxycycline effects on alveolar bone loss in post-menopausal women

Subantimicrobial dose doxycycline effects on osteopenic bone loss: microbiologic results

Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinase inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal anti-inflammatory drug

Subantimicrobial-dose doxycycline modulates gingival crevicular fluid biomarkers of periodontitis in postmenopausal osteopenic women

Subantimicrobial-dose doxycycline treatment increases serum cholesterol efflux capacity from macrophages

The effect of subantimicrobial-dose-doxycycline periodontal therapy on serum biomarkers of systemic inflammation: a randomized, double-masked, placebo-controlled clinical trial